Assessment of Measurable Residual Disease (MRD) in Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM) Among US Community Hematologists/ Oncologists (cH/O)

被引：0
|
作者：
Gajra, Ajeet
Rathish, Yamini S.
Jeune-Smith, Yolaine
Klink, Andrew J.
Feinberg, Bruce
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-142005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Minimally Invasive Assessment of Measurable Residual Disease (MRD) in Multiple Myeloma (MM)
    Gonzales, Carmen
    Lasa, Marta
    Notarfranchi, Laura
    Agullo, Cristina
    Cuenda, Natalia Buenache
    Zherniakova, Anastasiia
    Castro, Sergio
    Perez, Jose Juan
    Gonzalez-Calle, Veronica
    Romero, Maria Teresa Cedena
    Barrio, Santiago
    Martin-Munoz, Alejandro
    Burgos, Leire
    Alignani, Diego
    Calasanz, Maria Jose
    Otero, Paula Rodriguez
    Rosinol, Laura
    De Arriba, Felipe
    Ocio, Enrique M.
    Rocafiguera, Albert Oriol
    Palomera, Luis
    Gonzalez-Montes, Yolanda
    Balari, Anna Maria Sureda
    Garcia, Miguel Teodoro Hernandez
    Sanchez, Maria Esther Clavero
    Garcia, Angela Ibanez
    Gomez, Clara
    Orfao, Alberto
    Mateos, Maria Victoria
    Palacios, Juan Jose Lahuerta
    Blade, Joan
    San-Miguel, Jesus
    Martinez-Lopez, Joaquin
    Puig, Noemi
    Paiva, Bruno
    BLOOD, 2023, 142
  • [2] Insights into the Assessment of Measurable Residual Disease (MRD) in Patients With Multiple Myeloma
    Costa, Luciano J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (01) : 11 - 16
  • [3] Assessment of Measurable Residual Disease (MRD) in Multiple Myeloma: A Review of the Data
    Bal, Susan
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (01) : 3 - 10
  • [4] Assessment of Measurable Residual Disease (MRD) in Multiple Myeloma: A Review of the Data
    Wolf, Jeffrey
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (03)
  • [5] Perspectives of Single-Center Community Hematologists/Oncologists on Minimal Residual Disease Testing Among Patients With Multiple Myeloma
    Gordan, Lucio
    Warner, Amanda
    Heritage, Trevor
    Ming, Amy
    Gupta-Werner, Niodita
    Kaila, Shuchita
    Cortoos, Annelore
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S137 - S137
  • [6] Perspectives of Single-Center Community Hematologists/Oncologists on Minimal Residual Disease Testing Among Patients With Multiple Myeloma
    Gordan, Lucio N.
    Warner, Amanda
    Heritage, Trevor
    Ming, Amy
    Gupta-Werner, Niodita
    Kaila, Shuchita
    Cortoos, Annelore
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S546 - S546
  • [7] Best Practices for the Assessment of Measurable Residual Disease (MRD) in Multiple Myeloma: Further Observations
    Costa, Luciano J.
    Bal, Susan
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (01) : 17 - 17
  • [8] Assessment of minimal residual disease (MRD) after allogeneic bone marrow transplantation (BMT) for chronic lymphocytic leukemia (CLL)
    Esteve, J
    Villamor, N
    Colomer, D
    Rovira, M
    Carreras, E
    Rozman, C
    Montserrat, E
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 441 - 441
  • [9] A Clinical Perspective on Minimal Residual Disease (MRD) Assessment in Chronic Lymphocytic Leukemia
    Cheson, Bruce D.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (06) : 3 - 7
  • [10] Voyage of Measurable Residual Disease (MRD) Assessment in Multiple Myeloma Using Multiparametric Flow Cytometry
    Das, Nupur
    Gupta, Ritu
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2023, 44 (05) : 515 - 524
12345